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Introduction
The epidemiology, clinical relevance and management of vitamin D 
deficiency are medical issues of both academic and public interest. 
The role of vitamin D in calcium regulation and bone health has 
been well established,1 but recent evidence has identified associations 
between vitamin D deficiency and cardiovascular disease, diabetes, 
autoimmune disease, cancer of the prostate, breast and colon, as well 
as all-cause mortality.2-11 As vitamin D has over 1 000 human genes 
as direct targets, including skeletal muscle, heart, lungs and adrenal 
medulla,12,13 there may be potentially significant consequences of 
vitamin D deficiency on athletic performance. However, there are 
very few publications about the prevalence of vitamin D deficiency 
in elite athletes or the effects of vitamin D deficiency on athletic 
performance. This is the first article regarding vitamin D status in 
elite track and field athletes. 
Recent population studies have illustrated a significant prevalence 
of vitamin D deficiency in the general population,14-17 and athletes 
also seem to be susceptible.18-20 Serum 25(OH)D is widely accepted 
as a biomarker for vitamin D status.21 While some debate persists as 
to optimal levels of 25(OH)D for health, it is generally accepted that 
levels of 20 - 30 mcg/l represent vitamin D insufficiency while levels 
below 20 mcg/l and 10 mcg/l are defined as deficient and severely 
deficient, respectively.10 
Vitamin D is unique among nutrients in that almost all diets 
contain very little vitamin D and production primarily occurs 
in the skin, after exposure to ultraviolet B (UVB) sunlight.10,22 
Vitamin D cannot be effectively absorbed in the autumn and winter 
months in the UK because of the angle of the sun and atmospheric 
UVB absorption.23,24 In the UK, reduced levels of 25(OH)D have 
been reported in a number of studies.25-28 A large study of post-
menopausal women reported 77% of women with 25(OH)D levels 
<28 mcg/l.27 Deficiencies have also been noted in 78% of patients 
attending a UK rheumatology clinic26 and over 90% of an Asian 
cohort during a UK winter.25 
It has been widely recognised that mean 25(OH)D levels are 
lower in dark-skinned individuals at all ages, with greater risk of 
insufficiency and deficiency.29-31 This racial difference is primarily due 
to increased melanin pigmentation which reduces UVB absorption 
and subsequent vitamin D production.32 However, with recent public 
health campaigns emphasising the dangers of sunlight exposure 
and advocating intensive sun-block cream use, reports have also 
found high insufficiency rates, of around 60%, in the UK Caucasian 
population, and those with the fairest skin type to be, in fact, most 
deficient.28
There have been very few publications on vitamin D status in 
athletes. Recently, in a study of 93 Middle Eastern male athletes, 
91% were found to have a 25(OH)D level <20 mcg/l.18 A report of 18 
Abstract
Objective. While it is recognised that vitamin D deficiency is 
common in the general population, there have been no studies in 
elite athletes in the UK. This observational study aimed to assess 
the 25 hydroxy-vitamin D (25(OH)D) status of elite athletes  on 
the Great Britain track and field team. 
Methods.  A cross-sectional observational study was performed 
by analysing blood results from elite athletes on the British athletics 
team (N=63; mean ± standard deviation (SD) age 24.9±4.2 years). 
Athletes on the elite programme were offered blood tests through 
the winter and summer of 2009 and were eligible for inclusion in 
the study. 
Results. Nineteen per cent (n=12) of athletes in the current 
study can be classified as 25(OH)D deficient (<20 mcg/l), while a 
further 29% (n=18) can be classified as having insufficient serum 
25(OH)D levels (20 - 30 mcg/l). Female sex (insufficent and 
deficient OH(D) prevalence 58%, n=18) and dark skin (prevalence 
65%, n=20) were found to be independent predictors of serum 
25(OH)D levels of <30 mcg/l.
 Conclusion. This study reveals a notable prevalence of low serum 
25(OH)D levels in elite athletes and subsequent management of 
deficient athletes is likely to be of importance for athlete health. 
The impact of these results on athletic performance remains to be 
determined, and clinical trials to assess performance, particularly 
muscular performance, following correction of 25(OH)D status in 
deficient athletes are required.
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elite gymnasts in Australia noted 9 to be vitamin D insufficient and 
a further 6 to be vitamin D deficient.19 In a study of 9 - 15-year-old 
Finnish female athletes and non-athletes, 68% of all participants were 
found to have 25(OH)D levels <15 mcg/l.20 However, a small study 
on seven competitive road cyclists in the south of France identified 
adequate mean 25(OH)D levels of 32.4 mcg/l.33
While there are limited data on the effects of vitamin D 
deficiency on performance in athletes, the potential relationship 
with fracture risk34-36 and altered muscle function,37,38 in addition 
to the additional pathological associations noted above, would 
suggest that the identification and subsequent treatment of vitamin 
D deficiency in athletes is prudent. In the UK, track and field 
athletes would appear to be at significant risk of deficiency given 
the UK latitude (51 - 54°N), the indoor training environment and 
the proportion of dark-skinned athletes in the elite UK Athletics 
Track and Field team. Therefore, the aim of this study was to assess 
the 25(OH)D status of funded elite track and field athletes in the 
Great Britain team. 
Methods
Participants
All elite athletes funded on the UK Athletics World Class Performance 
Plan and training at UK Athletics High Performance Athletics Centres 
(N=80) were offered 25(OH)D testing throughout the 2008 - 2009 
season as part of a routine blood screening programme. Any athlete 
on this funded plan is considered to have the potential to win a medal 
at a World Championship or the Olympic Games. No athletes were 
taking high-dose vitamin D (>1 000 IU/day) supplementation in the 3 
months prior to the study. Other vitamin or mineral supplementation, 
including calcium intake, was not recorded. The study group 
comprised all athletes who underwent the blood test between 
December 2008 and August 2009 (N=63) and completed informed 
written consent for the study. 
Data collection 
Age, sex and skin colour were recorded. Skin colour was defined 
as either fair-skinned (white Caucasian) or dark-skinned (Afro-
Caribbean). The athlete’s place of residence and training location 
(indoor or outdoor) for the previous 2 months were also recorded. 
Their competitive event was categorised as either endurance (race 
distances at or above 800 m) or sprint/power (all other track and field 
disciplines). The month of testing was recorded and categorised as 
either winter (December - March) or summer (April - August). 
Blood sampling
Blood samples were collected by standard venepuncture using a 
10 ml syringe and 23 gauge needle. There was no standard fasting 
procedure before testing. For athletes tested in Birmingham (n=5) 
blood samples were analysed at the Birmingham Heartlands Hospital, 
those in Loughborough (n=17) at the Leicester Royal Infirmary and 
those in London (n=41) were tested at the Hospital of St John and St 
Elizabeth. Laboratories in London and Loughborough used the same 
manufacturer’s chemiluminescent immunoassay (Liason, Diasorin® 
Dartford, Kent). No repeated sampling with the same athlete was 
done to compare different laboratories. The Birmingham Heartlands 
Table 1. Socio-demographics and other characteristics of the 
subjects
Variable Frequency Percentage
Gender
Females 31 49
Males 32 51
Endurance
Endurance 19 30
Sprint/power 44 70
Skin
Dark 31 49
Fair 32 51
Residence
Japan 1 2
London 32 51
Midlands 17 27
North England 7 11
Southern Europe 2 3
Southern USA 4 6
Training environment
Indoors 20 32
Outdoors 43 68
Month of test
Dec 2 3
Jan 9 14
Feb 5 8
Mar 8 13
Apr 8 13
May 11 18
Jun 8 13
Jul 11 18
Aug 1 2
Season during test
Summer 39 62
Winter 24 38
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Fig. 1. Distribution of 25(OH)D level: deficient (vertical lines); 
insufficient (diagonal hash); sufficient (white).
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Hospital laboratory used an HPLC tandem mass spectrometer 
(Applied Biosystems, Warrington Cheshire). 
Insufficient 25(OH)D levels were defined as <30 mcg/l and 
deficiency as <20 mcg/l.10 
Statistical t-tests were performed to assess differences between the 
variables noted above, under data collection, and regression analysis 
was used to identify independent predictors for 25(OH)D deficiency. 
A p-value of <0.05 was considered significant. The independent 
predictors assessed by regression analysis were location, sex, training 
environment, skin colour, athletic event and season of testing. The 
study was granted ethical approval by Queen Mary’s University of 
London Ethics panel (QMREC2010/84).
Results 
Demographics
Sixty-three subjects (mean ± standard deviation (SD) age 24.9±4.2 
years) had their serum 25(OH)D level measured. Their socio-
demographic and other characteristics are noted in Table 1. All dark-
skinned athletes were Afro-Caribbean. Seventeen athletes eligible for 
the study did not take up the offer of the blood test.
25(OH)D status in elite track and field athletes
Overall analysis identified a mean (±SD) serum concentration of 
25(OH)D of 31.5±15.1 mcg/l (N=63). An insufficient 25(OH)D status 
was noted in 29% (n=18) of athletes and a further 19% (n=12) were 
deficient with levels <20 mcg/l (Fig. 1). 
Risk factors for low 25(OH)D status
Female athletes, dark-skinned athletes and those tested in the winter 
months were all noted to have significantly lower 25(OH)D levels 
(Table 2). Subsequent regression analysis, on variables of sex, age, 
location, season, skin colour and athletic discipline, identified female 
sex and dark skin as independent predictors for low 25(OH)D levels. 
Analysis of the 15 dark-skinned athletes tested in the winter found 
3 (20%) athletes to be insufficient and a further 8 (53%) deficient. In 
the summer 7 of 16 (44%) dark-skinned athletes were insufficient and 
2 (13%) were deficient (Table 3). Of the tests performed on female 
athletes with dark skin 54% were deficient and a further 31% had 
insufficient levels. There were no male athletes with fair skin noted to 
be deficient (Table 4).
Discussion
This is the largest published study on 25(OH)D levels in elite 
international athletes. It provides clear evidence of a notable prevalence 
of 25(OH)D insufficiency and deficiency in elite UK track and field 
athletes. It should be recognised that this study is an observational 
cross-sectional study in our elite athlete group and there are no 
control group data from non-elite athletes or the general population. 
However, the aim of the study was to determine the prevalence of 
25(OH)D deficiency in athletes. Two differing laboratory techniques 
were used to determine 25(OH)D levels with the resultant possibility 
of inter-laboratory variability. There were no significant differences 
between the mean 25(OH)D levels in the groups assessed by each 
laboratory.
The prevalence rates reported here support those of previous 
studies in young adults.17,39 In the USA and Canada 36% of young 
adults have been noted to be deficient in the winter,39 which compares 
with our winter figure of 38%. Our overall prevalence of deficiency 
throughout the year of 19%, with insufficiency in a further 28%, is 
similar to published work relating to adolescents in northern USA 
(latitude 42°N) which noted 24% of subjects with levels <15 mcg/l.17 
By comparison, in Middle Eastern national level athletes from a 
variety of sports, 93% of athletes were noted to be deficient and, in 
Australia, 33% of 18 gymnasts were found to be deficient.18,19 
In our cohort, skin colour and sex were noted to be significant 
independent predictors of vitamin D status. The remarkable prevalence 
of deficiency in 54% of dark-skinned female athletes (and insufficient 
levels in a further 31%) is still comparable with some published literature 
in older groups of a similar skin colour.29 Skin colour is well recognised 
as a predictor of vitamin D status with numerous studies identifying 
lower levels in individuals with dark skin.29-31 This is primarily due to 
increased melanin content reducing UVB absorption and subsequent 
vitamin D production.32 It has also been reported that seasonal 
Table 2. Differences in 25(OH)D levels by gender, event, skin 
colour, training venue and season
25(OH)D level (mean±SD), mcg/l p-value
Gender 0.014
Male 36.1±15.7
Female 26.8±13.2
Event 0.509
Endurance 33.2±11.1
Sprint/power 30.8±16.7
Skin colour <0.001
Dark 24.9±11.0
Fair 37.9±16.0
Training Venue 0.016
Indoors 24.2±16.6
Outdoors 34.9±13.3
Season 0.005
Summer 35.4±15.8
Winter 25.2±11.8
Table 3. Proportion of vitamin D deficient and insufficient 
athletes by skin colour and season
Skin colour Season n Insufficient, n (%) Deficient, n (%)
Dark-skinned Winter 15 3 (20) 8 (53)
Dark-skinned Summer 16 2 (13) 7 (44)
Fair-skinned Winter 9 3 (33)
Fair-skinned Summer 23 5 (22) 1 (4)
Table 4. Proportion of vitamin D deficient and insufficient 
athletes by skin colour and gender
Skin colour Gender n Insufficient, n (%) Deficient, n (%)
Dark-skinned Female 13 4 (31) 7 (54)
Dark-skinned Male 18 6 (33) 3 (17)
Fair-skinned Female 18 5 (28) 2 (11)
Fair-skinned Male 14 2 (14) 0 (0)
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differences in 25(OH)D levels, while apparent in other populations, 
is less evident in dark-skinned individuals.40 This is supported by our 
study, which found that season was not an independent predictor and 
prevalence of deficiency and insufficiency were similar in the dark-
skinned group throughout the year, presumably because of persisting 
reduction in cutaneous production. 
However, in addition to melanin content, social behaviour such as 
sun exposure and clothing should also be considered when reviewing 
an athlete’s risk of developing vitamin D deficiency. In studies of Middle 
Eastern groups, females have been reported to have significantly lower 
25(OH)D levels.41-43 This has been attributed to required clothing 
covering all skin and thereby reducing exposure to UVB.44 
In South Africa, the Mediterranean and other sun-rich areas the 
relevance of this study may not be immediately apparent. While 
individuals in sun-rich areas may be at less risk,45 a number of studies 
have shown a significant prevalence of vitamin D deficiency in these 
areas,46,47 potentially due to an individual’s skin colour or sunscreen 
application. Our study findings would support the assertion that clinicians 
in any geographical area with a significant population of dark-skinned 
individuals should be mindful of the possibility of vitamin D deficiency. 
Sex was a significant independent predictor in our study and 
this has been noted in other populations.48 It is possible that the 
application of sunscreen, UVB-blocking moisturiser or make-up 
may enhance the risk of developing deficiency. Unfortunately we do 
not have information on hours of sun exposure or the use of sun-
protection agents; further work is required. However, if these findings 
were corroborated in a larger athlete group, vitamin D deficiency may 
be an additional aetiological risk factor for the increased incidence of 
stress fractures in female athletes.49-54 
Insufficient serum concentration of 25(OH)D is known to increase 
parathyroid hormone (PTH) secretion, increasing bone turnover and 
bone resorption.55 In a prospective study, in Finnish army recruits, 
high serum PTH levels were identified as a risk factor for stress 
fracture development.56 In two studies lower 25(OH)D levels have 
been found to be associated with a significantly increased risk of stress 
fracture in young Finnish men57 and with high-grade stress fractures, 
in a large army cohort.58 One randomised controlled trial of  more 
than 5 000 army recruits reports a reduction in stress fractures after 
daily supplementation of 2 g calcium and 800 IU vitamin D.59 
In addition to the classic role in bone metabolism, vitamin D 
deficiency may directly impact on athletic performance through other 
physiological mechanisms including muscle function,38,60-62 immunity 
and the potential mediation of exercise-induced inflammation.63,64 
The vitamin D receptor and intracellular vitamin D regulation have 
also been identified in heart muscle, liver, lung and adrenal systems, 
all of which are determinants of athletic performance.13,65,66 
However, the direct evidence for treatment of vitamin D 
deficiency to improve performance is extremely weak. High-
quality trials in athletic populations are required to determine 
the effects of correcting vitamin D deficiency and insufficiency 
on athletic, and particularly muscular, performance. There remain 
many questions regarding optimal 25(OH)D serum concentration 
and management of deficiency in athletes, and indeed the wider 
population. Management may include increased sunlight exposure, 
dietary fortification and medication such as cholecalciferol. 
However, as this study reveals, athletes are at risk of 25(OH)D 
deficiency and, for the reasons discussed above, we recommend 
that sport and exercise medicine physicians are mindful of 
assessing vitamin D status. 
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